These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4212215)

  • 1. Oral and intravenous toxicity of delta9-tetrahydrocannabinol in rhesus monkeys.
    Thompson GR; Fleischman RW; Rosenkrantz H; Braude MC
    Toxicol Appl Pharmacol; 1974 Mar; 27(3):648-65. PubMed ID: 4212215
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral delta9-tetrahydrocannabinol toxicity in rats treated for periods up to six months.
    Rosendrantz H; Sprague RA; Fleischman RW; Braude C
    Toxicol Appl Pharmacol; 1975 May; 32(2):399-417. PubMed ID: 1171539
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys.
    Thompson GR; Rosenkrantz H; Schaeppi UH; Braude MC
    Toxicol Appl Pharmacol; 1973 Jul; 25(3):363-72. PubMed ID: 4199474
    [No Abstract]   [Full Text] [Related]  

  • 4. 9 -Tetrahydrocannabinol: effects of EEG and behavior of rhesus monkeys.
    Martinez JL; Stadnicki SW; Schaeppi UH
    Life Sci I; 1972 Jul; 11(13):643-51. PubMed ID: 4632405
    [No Abstract]   [Full Text] [Related]  

  • 5. Subacute toxicity of aqueous-suspended 9 -tetrahydrocannabinol in rats.
    Phillips RN; Brown DJ; Martz R; Hubbard JD; Forney RB
    Toxicol Appl Pharmacol; 1972 May; 22(1):45-9. PubMed ID: 5064307
    [No Abstract]   [Full Text] [Related]  

  • 6. Behavioral effects in rhesus monkeys of repeated intravenous doses of 9-tetrahydrocannabinol.
    Harris RT; Waters W; McLendon D
    Psychopharmacologia; 1972; 26(3):297-306. PubMed ID: 5073049
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute, subacute and 23-day chronic marihuana inhalation toxicities in the rat.
    Rosenkrantz H; Braude M
    Toxicol Appl Pharmacol; 1974 Jun; 28(3):428-41. PubMed ID: 4850426
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute tolerance to the effects of delta-9-tetrahydrocannabinol on spaced responding by monkeys.
    Manning FJ
    Pharmacol Biochem Behav; 1973; 1(6):665-71. PubMed ID: 4206609
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term use of marihuana and the development of tolerance or sensitivity to delta9 tetrahydrocannabinol.
    Perez-Reyes M; Timmons MC; Wall ME
    Arch Gen Psychiatry; 1974 Jul; 31(1):89-91. PubMed ID: 4835989
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of marihuana (delta-9-tetrahydrocannabinol) on the secretion of luteinizing hormone in the ovariectomized rhesus monkey.
    Besch NF; Smith CG; Besch PK; Kaufman RH
    Am J Obstet Gynecol; 1977 Jul; 128(6):635-42. PubMed ID: 406789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and parenteral formulations of marijuana constituents.
    Rosenkrantz H; Thompson GR; Braude MC
    J Pharm Sci; 1972 Jul; 61(7):1106-12. PubMed ID: 4625586
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months.
    Luthra UL; Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1975 May; 32(2):418-31. PubMed ID: 1171540
    [No Abstract]   [Full Text] [Related]  

  • 13. Great apes and rhesus monkeys as subjects for psychopharmacological studies of stimulants and depressants.
    Pieper WA
    Fed Proc; 1976 Sep; 35(11):2254-7. PubMed ID: 821785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delta9-tetrahydrocannabinol and 11-hydroxy-delta9-tetrahydrocannabinol: behavioral effects and tolerance development.
    Kosersky DS; McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1974 Apr; 189(1):61-5. PubMed ID: 4823300
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of delta-9-tetrahydrocannabinol on temporal and auditory discrimination performances of monkeys.
    Elsmore TF
    Psychopharmacologia; 1972; 26(1):62-72. PubMed ID: 4626286
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhalation, parenteral and oral LD50 values of delta 9-tetrahydrocannabinol in Fischer rats.
    Rosenkrantz H; Heyman IA; Braude MC
    Toxicol Appl Pharmacol; 1974 Apr; 28(1):18-27. PubMed ID: 4852457
    [No Abstract]   [Full Text] [Related]  

  • 17. Water-soluble derivatives of 1 -tetrahydrocannabinol.
    Zitko BA; Howes JF; Razdan RK; Dalzell BC; Dalzell HC; Sheehan JC; Pars HG; Dewey WL; Harris LS
    Science; 1972 Aug; 177(4047):442-4. PubMed ID: 5043146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term delta-9-tetrahydrocannabinol treatment. Computed tomography of the brains of rhesus monkeys.
    McGahan JP; Dublin AB; Sassenrath E
    Am J Dis Child; 1984 Dec; 138(12):1109-12. PubMed ID: 6095645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of teratological effects of intravenous, subcutaneous, and intragastric administration of delta9-tetrahydrocannabinol in mice.
    Joneja MG
    Toxicol Appl Pharmacol; 1976 Apr; 36(1):151-62. PubMed ID: 1273835
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of chronic exposure to delta9-tetrahydrocannabinol on delayed matching-to-sample in chimpanzees.
    Ferraro DP; Grilly DM
    Psychopharmacologia; 1974 Jun; 37(4):127-38. PubMed ID: 4844118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.